Lundeos, capsule molle

7680677960017 CH-67796 capsule molle

Associated product:

LUNDEOS caps moll 20000 UI 4 pce
Lundeos, capsule molle
Lundeos, capsule molle
Lundeos, capsule molle
1 / 3
google

Article details

Package size
4
Selling units
4
Measure
Kapsel(n)
Galenic form
capsule molle
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/09/2025
Patient information leaflet
Français
02/09/2025
Patient information leaflet
Italien
02/09/2025
Summary of Product Characteristics
Allemand
02/09/2025
Summary of Product Characteristics
Français
02/09/2025
Summary of Product Characteristics
Italien
02/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20000.0 UI Substance Wirkstoff (Principe actif)
(N/A)
500.0 UG Substance WIIS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 13.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2022

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
67796
Drug name
Lundeos, capsule molle
Galenic form
KAPWE
ATC Code
A11CC05
Authorization status
Z
Dispensing category
B
First authorization
17/02/2022
Authorization expiration date
16/02/2027
IT Number
07.02.3.
Domain
Human medicine
Field of application
Therapie des Vitamin D-Mangels bei Erwachsenen und Jugendlichen ab 12 Jahren. Prophylaxe eines Vitamin D-Mangels bei Erwachsenen bis 60 Jahren und Jugendlichen ab 12 Jahren.

Package details

Description (FR)
LUNDEOS caps moll 20000 UI 4 pce
Description (DE)
LUNDEOS Weichkaps 20000 IE 4 Stk
Market launch
17/02/2022
Narcotic (BTM)
No

Other package sizes (1)

LUNDEOS caps moll 20000 UI 2 x 4 pce
2 x 4 KAP
GTIN: 7680677960031
View